deltatrials
Completed PHASE2/PHASE3 NCT01408446

Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients

A Randomized, Double-Blind, Placebo Control Trial Comparing Effects and Safety of DANSHU Capsule(Menthol) and Placebo on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients

Sponsor: Zhiming Zhu

Conditions Hypertension Prehypertension
Interventions Menthol Placebo
Updated 7 times since 2017 Last updated: Mar 7, 2020 Started: Aug 1, 2012 Primary completion: Jun 1, 2013 Completion: Aug 30, 2013

This PHASE2/PHASE3 trial investigates Hypertension and Prehypertension and is currently completed. Zhiming Zhu leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

    Status: Recruiting → Completed

  5. Sep 2018 — Apr 2020 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Unknown Status → Recruiting

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Unknown Status PHASE2_PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2_PHASE3

    First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Zhiming Zhu
Data source: Third Military Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Chongqing, China